Heterogeneity and progesterone-receptor distribution in endometrial adenocarcinoma
- 1 January 1984
- Vol. 53 (1) , 113-116
- https://doi.org/10.1002/1097-0142(19840101)53:1<113::aid-cncr2820530120>3.0.co;2-f
Abstract
Objective response to progestin therapy occurs in 30% to 35% of patients with recurrent or metastatic endometrial carcinoma. Measurement of progesterone receptor (PR) in these tumors has been suggested as a method for distinguishing between responders and nonresponders. However, studies on steroid receptor measurements in endometrial carcinoma may be subject to complexities of tumor, tissue, and cellular heterogeneity. The authors provide evidence for the existence of various types of heterogeneity and address the problem of cellular heterogeneity by determination of PR concentrations in the glandular and stromal cells of the endometrium. It is concluded that until the problem of tumor and tissue heterogeneity is resolved, PR concentrations in endometrial carcinoma must be interpreted with caution. Cancer 53:113-116, 1984.This publication has 13 references indexed in Scilit:
- Distribution of Progesterone Receptor, Estradiol Dehydrogenase, and 20α-Dihydroprogesterone Dehydrogenase Activities in Human Endometrial Glands and Stroma: Progestin Induction of Steroid Dehydrogenase Activities in Vitro Is Restricted to the Glandular Epithelium*Endocrinology, 1982
- The uneven distribution of estrogen and progesterone receptors in human endometriumThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administrationInternational Journal of Cancer, 1979
- Isolation and Culture of Human Endometrial Glands*Journal of Clinical Endocrinology & Metabolism, 1979
- Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapyInternational Journal of Cancer, 1979
- Hormones and Their Receptors in Breast CancerPublished by Elsevier ,1978
- Characterization and Properties of Progesterone-Binding Components in Human Endometrium1Journal of Clinical Endocrinology & Metabolism, 1974
- Medroxyprogesterone in the management of primary and recurrent or metastatic uterine adenocarcinomaPublished by Wiley ,1972
- In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometriumAmerican Journal of Obstetrics and Gynecology, 1971
- Progestational Agents in the Treatment of Carcinoma of the EndometriumNew England Journal of Medicine, 1961